Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0003 (150.00%)
At close: Sep 25, 2026
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $25.15 thousand as of September 25, 2026. Its market cap has decreased by -95.27% in one year.
Market Cap
25.15K
Enterprise Value
544.15K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 25.15K, a decrease of -99.92%. That is a compound annual growth rate of -31.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 25.15K | -95.46% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxxinity | 12.68K |
| NovAccess Global | 12.33K |
| Trevena | 10.74K |
| Syros Pharmaceuticals | 10.73K |
| GeneLink | 10.60K |
| Navidea Biopharmaceuticals | 10.00K |
| Windtree Therapeutics | 9.00K |
| Bioasis Technologies | 7.94K |